House Bill 371 aimed to prohibit the administration of gene-based vaccines, including those using messenger RNA (mRNA) or deoxyribonucleic acid (DNA) technology, to humans within the state of Montana. The bill proposed that anyone providing or administering such a vaccine would be guilty of a misdemeanor, facing a $500 fine for each incident. It also required the relevant licensure board to review the license of any professional who violated this prohibition. This legislation would directly affect healthcare providers and individuals seeking these specific types of vaccines in Montana.
House Bill 556 regulates how health insurance issuers use artificial intelligence (AI) for reviewing and managing healthcare services. It prohibits AI, algorithms, or other software tools from solely determining medical necessity or denying, delaying, or modifying healthcare services. Instead, medical necessity determinations must be made by licensed healthcare professionals, considering individual patient history and circumstances, not just group data. The bill also requires AI tools to be applied fairly, avoid discrimination, and be open to audit, making non-compliance an unfair claim settlement practice.
HB 797, also known as the "Expanding Physician Access Act," aims to revise occupational licensing laws to facilitate the licensure of international physicians. The bill establishes a process for the board to grant provisional licenses to international physicians who meet specific educational, examination, and experience requirements, and have an employment offer from a healthcare provider in the state. These provisional licenses automatically convert to full licenses after three years of continuous active practice in the state. This initiative seeks to remove barriers for internationally licensed physicians to fill vacancies, particularly in rural and primary care settings, while maintaining existing standards of care and licensing requirements.
HB 290 aimed to regulate products containing Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) within the state. Starting January 1, 2028, it would prohibit the manufacture, sale, or offer for sale of cosmetics, juvenile products, and menstrual products that contain intentionally added PFAS. Manufacturers would be required to provide a certificate of compliance for these products. Additionally, the bill would prohibit the use of class B firefighting foam containing intentionally added PFAS for training purposes from January 1, 2028, and regulate its emergency use at terminals, requiring annual notice and justification to the state fire marshal.
HB 828, known as the "Powered Wheelchair Right to Repair Act," sought to revise consumer rights laws related to powered wheelchair repairs. The bill would have required original equipment manufacturers to provide powered wheelchair owners and independent repair businesses with access to documentation, parts, and tools needed for diagnosis, maintenance, and repair. These resources were to be made available on fair and reasonable terms, including free electronic documentation and tools, and parts at costs equivalent to those offered to authorized repair providers. Additionally, manufacturers would have been required to provide tools to access and reset electronic security locks for repair purposes. Violations of these provisions would have been considered an unlawful practice under state consumer protection laws.
HB 943 establishes the Montana Rare Disease Advisory Council within the Department of Public Health and Human Services. This 17-member council, composed of patients, caregivers, medical professionals, researchers, and other stakeholders, will provide guidance, education, and recommendations on the needs of individuals with rare diseases in Montana. Its duties include surveying patient needs, developing policy recommendations for improved access to care and treatment, publishing resources, and identifying research opportunities. The council is required to meet regularly and submit annual reports to the Governor and Legislature, and the bill includes an appropriation to cover initial costs.
HB 807 amends state law to prohibit individuals from being required to receive certain vaccines. Specifically, it mandates that vaccines whose use is allowed under an emergency use authorization (EUA) or those still undergoing safety trials cannot be a requirement. This applies to persons, governmental entities, employers, and public accommodations, preventing them from denying services, employment, or access based on non-receipt of such vaccines. The bill integrates this new prohibition into existing law concerning discrimination based on vaccination status.
HB 867 establishes a medical assistance program specifically for licensed chiropractors and veterinarians. This program provides support and monitors rehabilitation for these professionals who are impaired by substance abuse, mental illness, or chronic physical illness. To fund this initiative, the bill allows the respective boards to adjust the license renewal fees for chiropractors and veterinarians. It also updates existing laws concerning the confidentiality and auditing of professional medical assistance programs to include these new licensee groups.
HB 920 establishes a temporary property tax exemption for new senior care facilities and housing development projects. Tax-exempt non-profit organizations sponsoring these projects must first petition a local government, which determines if there is a "compelling need" for the project through a public hearing. If approved by the local government, the sponsor can then apply to the department of revenue for the exemption. This bill aims to encourage the development of various affordable housing and care options for seniors aged 55 or 62 and older.
HB 794 revises general pharmacy laws, impacting pharmacies, pharmacy technicians, and clinical pharmacist practitioners. The bill updates and clarifies definitions, removes the utilization plan requirement for in-state and mail-order pharmacies, and mandates an endorsement for clinical pharmacist practitioners. It also eliminates outdated notification practices for biosimilar drug selection and generic drug signage requirements. Additionally, the bill clarifies pharmacy wholesale distribution licenses and the powers of the Board of Pharmacy, and adjusts provisions for insurance plans regarding out-of-state mail-order pharmacies.